Should companies not publish the results of all trials ever done for drugs that went into use?, asked Bokani Tshidzu, of Vertigo Ventures. Sir Peter Dixon, the chair of Diabetes UK, agreed, warning that people will not believe that drug firms have changed “until everything is out there”.